Lymphoma (includes NHL, HL, CNS Lymphoma)
Featured Articles
(Medscape Medical News) June 26, 2017 - Patients with advanced Hodgkin's lymphoma who show early metabolic response on FDG-PET scans can safely and effectively be switched to a reduced chemotherapy regimen, say researchers.
Read Article
(Forbes) June 26, 2017 - In a closely watched result, Adcetris, a cancer drug sold by the biotech firm Seattle Genetics and the Japanese drug giant Takeda, outperformed traditional chemotherapy in front-line Hodgkin lymphoma, a result that is likely to lead to a broadened approval from the Food and Drug Administration.
Read Article
Latest Articles
June 26, 2017
June 26, 2017
June 23, 2017
June 23, 2017
June 23, 2017
June 23, 2017
June 20, 2017
June 19, 2017
View More
OBR Green
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) OBR Green articles.
OBR Blog
Introduction In an effort to provide you with timely market feedback from the 58th ASH Annual Meeting held in December... Read more
January 06, 2017
By: Greg Wolfe, Ph.D., Senior Consultant, Clinical & Scientific Assessment, Kantar Health and Jay Grisolano, Ph.D.,... Read more
December 07, 2016